Ezequiel Ridruejo

Summary

Publications

  1. doi request reprint Safety of direct-acting antivirals in the treatment of chronic hepatitis C
    Ezequiel Ridruejo
    Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Department of Medicine, Hepatology Section, Avda Las Heras 2939, C1425ASG Ciudad Autónoma de Buenos Aires, Argentina 54 11 5299 1221 54 11 5299 0600 ext 5900
    Expert Opin Drug Saf 13:307-19. 2014
  2. ncbi request reprint Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    Ezequiel Ridruejo
    Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Avda Las Heras 2981 C1425ASG Ciudad Autónoma de Buenos Aires, Argentina 54 11 5299 1221 54 11 5299 0600 ext 5900
    Expert Opin Drug Saf 11:357-60. 2012
  3. ncbi request reprint Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin
    Ezequiel Ridruejo
    Hepatology Section, Department of Medicine Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Ciudad Autonoma de Buenos Aires, Argentina
    Ann Hepatol 10:452-7. 2011
  4. doi request reprint Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice
    E Ridruejo
    Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
    Int J Clin Pract 65:866-70. 2011
  5. doi request reprint Thioctic acid-induced acute cholestatic hepatitis
    Ezequiel Ridruejo
    Hepatology Section, Department of Internal Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Buenos Aires, Argentina
    Ann Pharmacother 45:e43. 2011
  6. ncbi request reprint Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C
    Ezequiel Ridruejo
    Nephrology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC
    Ann Hepatol 9:271-7. 2010
  7. ncbi request reprint Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon - Ribavirin in daily practice
    Ezequiel Ridruejo
    Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, CEMIC, Ciudad Autonoma de Buenos Aires, Argentina
    Ann Hepatol 9:46-51. 2010
  8. ncbi request reprint HBsAg as predictor of outcome in renal transplant patients
    Ezequiel Ridruejo
    Sección Hepatología, Departamento de Medicina, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Buenos Aires, Argentina
    Medicina (B Aires) 64:429-32. 2004
  9. ncbi request reprint Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin
    Ezequiel Ridruejo
    Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Buenos Aires, Argentina
    Eur J Gastroenterol Hepatol 18:693-4. 2006
  10. ncbi request reprint Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study
    Eduardo Fassio
    Hospital Nacional Prof A Posadas, Buenos Aires, Argentina
    Ann Hepatol 9:63-9. 2010

Detail Information

Publications14

  1. doi request reprint Safety of direct-acting antivirals in the treatment of chronic hepatitis C
    Ezequiel Ridruejo
    Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Department of Medicine, Hepatology Section, Avda Las Heras 2939, C1425ASG Ciudad Autónoma de Buenos Aires, Argentina 54 11 5299 1221 54 11 5299 0600 ext 5900
    Expert Opin Drug Saf 13:307-19. 2014
    ..Treatment with the next generation of antivirals will improve safety and efficacy. ..
  2. ncbi request reprint Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    Ezequiel Ridruejo
    Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Avda Las Heras 2981 C1425ASG Ciudad Autónoma de Buenos Aires, Argentina 54 11 5299 1221 54 11 5299 0600 ext 5900
    Expert Opin Drug Saf 11:357-60. 2012
    ..Although major AEs are infrequent, they can be initially clinically silent yet lead to serious medical problems, therefore, a proactive surveillance and their prompt management is recommended...
  3. ncbi request reprint Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin
    Ezequiel Ridruejo
    Hepatology Section, Department of Medicine Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Ciudad Autonoma de Buenos Aires, Argentina
    Ann Hepatol 10:452-7. 2011
    ..The importance of these IL28B variants for Argentine patients remains unknown...
  4. doi request reprint Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice
    E Ridruejo
    Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
    Int J Clin Pract 65:866-70. 2011
    ..Registration studies showed entecavir (ETV) to be effective and safe in NUC-naïve patients with chronic hepatitis B virus (HBV), but its effectiveness in routine clinical practice is unknown...
  5. doi request reprint Thioctic acid-induced acute cholestatic hepatitis
    Ezequiel Ridruejo
    Hepatology Section, Department of Internal Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Buenos Aires, Argentina
    Ann Pharmacother 45:e43. 2011
    ..To report a case of severe cholestatic hepatitis caused by thioctic acid in a patient with diabetic peripheral polyneuropathy and mild chronic renal failure...
  6. ncbi request reprint Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C
    Ezequiel Ridruejo
    Nephrology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC
    Ann Hepatol 9:271-7. 2010
    ..There is no agreement upon the influence of chronic hepatitis B (HBV) and hepatitis C (HCV) infection in patient and graft survival...
  7. ncbi request reprint Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon - Ribavirin in daily practice
    Ezequiel Ridruejo
    Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, CEMIC, Ciudad Autonoma de Buenos Aires, Argentina
    Ann Hepatol 9:46-51. 2010
    ..Efficacy and safety of Pegylated Interferon alfa (PegIFN)-Ribavirin (RBV) for the treatment of chronic hepatitis C (CHC) in routine clinical practice seems to be comparable with results of randomized-controlled trials...
  8. ncbi request reprint HBsAg as predictor of outcome in renal transplant patients
    Ezequiel Ridruejo
    Sección Hepatología, Departamento de Medicina, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Buenos Aires, Argentina
    Medicina (B Aires) 64:429-32. 2004
    ....
  9. ncbi request reprint Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin
    Ezequiel Ridruejo
    Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Buenos Aires, Argentina
    Eur J Gastroenterol Hepatol 18:693-4. 2006
    ..This is the first report of central hypothyroidism and hypophysitis during treatment with PEG-IFN-alpha plus ribavirin, and may be included in the potential list of side effects of the combination treatment...
  10. ncbi request reprint Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study
    Eduardo Fassio
    Hospital Nacional Prof A Posadas, Buenos Aires, Argentina
    Ann Hepatol 9:63-9. 2010
    ..Secondary aims were to evaluate staging using Okuda and BCLC classifications; and percentage of patients receiving treatment...
  11. pmc Hepatitis C virus diversification in Argentina: comparative analysis between the large city of Buenos Aires and the small rural town of O'Brien
    Marcelo D Golemba
    Catedra de Virologia, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Buenos Aires, Argentina
    PLoS ONE 8:e84007. 2013
    ....
  12. ncbi request reprint Imatinib-induced fatal acute liver failure
    Ezequiel Ridruejo
    Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, CEMIC, Avda Las Heras 2939, Buenos Aires, Argentina
    World J Gastroenterol 13:6608-111. 2007
    ..Liver function tests should be carefully monitored during treatment and, with the appearance of any elevation of liver function tests, treatment should be discontinued...
  13. pmc Chylous ascites as the main manifestation of left ventricular dysfunction: a case report
    Ezequiel Ridruejo
    Hepatology Section, Department of Internal Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Buenos Aires, Argentina
    BMC Gastroenterol 5:25. 2005
    ..Ascites is one of the most common complications of liver diseases, even though in 15% of the cases it is related to extrahepatic diseases; 3% are of cardiac nature and they appear associated with signs and symptoms of heart failure...
  14. ncbi request reprint Severe cholestatic hepatitis as the first symptom of secondary syphilis
    Ezequiel Ridruejo
    Hepatology Section, Department of Internal Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Avenida Las Heras 2939, Buenos Aires C1425ASG, Argentina
    Dig Dis Sci 49:1401-4. 2004